Related Experiment Video
Updated: Sep 2, 2025
Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
Published on: January 19, 2024
Spending and Hospital Stay for Melanoma in Hunan, China
Xinchen Ke1,2,3,4, Wenrui Lin1,2,3,4, Daishi Li1,2,3,4
1Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China.
Objective:
This study aimed to describe the economic burden of Chinese patients with melanoma in Hunan province of China, and to investigate the factors for hospitalization spending and length of stay (LOS) in patients undergoing melanoma surgery.
Methods:
Data was extracted from the Chinese National Health Statistics Network Reporting System database in Hunan province during 2017-2019. Population and individual statistics were presented, and nonparametric tests and quantile regression were used to analyze the factors for spending and LOS.
Result:
A total of 2,644 hospitalized patients with melanoma in Hunan were identified. During 2017-2019, the total hospitalization spending was $5,247,972, and out-of-pocket payment (OOP) was $1,817,869, accounting for 34.6% of the total expenditure. The median spending was $1,123 [interquartile range (IQR): $555-2,411] per capita, and the median LOS was 10 days (IQR: 5-18). A total of 1,104 patients who underwent surgery were further analyzed. The non-parametric tests and quantile regression showed that women were associated with less spending and LOS than men. In general, patients aged 46-65 and those with lesions on the limbs had higher hospitalization costs and LOS than other subgroups.
Conclusion:
Melanoma causes heavy economic burdens on patients in Hunan, such that the median spending is close to 60% of the averagely annual disposable income. Middle-aged men patients with melanoma on the limbs present the highest financial burden of melanoma.
